New biodegradable anal plug to manage Faecal Incontinence

Informazioni relative al progetto

My-qup

ID dell’accordo di sovvenzione: 744432

DOI 10.3030/744432

Progetto chiuso

Data della firma CE 1 Dicembre 2016

Data di avvio 1 Gennaio 2017

Data di completamento 30 Giugno 2017

Finanziato da

• SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials

Costo totale € 71 429,00

Contributo UE € 50 000,00

Coordinato da

MY-QUP MEDICAL SL
Spain

Obiettivo

My-qup is developing an anal plug, qup, for the management of faecal incontinence (FI) that will reduce the environmental impact that other solutions like pads, diapers and non degradable anal plugs produce. It will be sold to autonomous patients to help them recover their Quality of Life (QoL). FI affects most parts of the patient's life, including laboral, social and sex life. qup users will be able to regain control of their defecation, providing enough safety to return to their previous lifestyle. My-qup Medical considers the whole user experience with a holistic design that tackles all the sides of conservative treatment (non-surgical treatment) and management of FI.

The main achievements of the project are the innovation in the material and the design. It will significantly reduce waste and use of resources. The material has been developed to comply with the European Guides of flushability. The next challenges for the product are to prove the usability and efficacy with the users, and to find manufacturers to start a small production to conduct a clinical trial.

The estimated global market of FI is USD 2,000 MM with an estimated prevalence of a 10% of adult population with a growing incidence due to an aging population. There are 93 million potential users in the developed world that will be, in most cases, chronic patients. The potential client of My-qup Medical will be the user of qup: autonomous patients that, if it wasn’t for this condition, could have a normal life. As FI is a global problem, after reaching the developed world it will be necessary to study the entry in developing countries.

SME Instrument Phase I would serve to assess: the feasibility of licensing vs. reaching the market, the usability of the product (including efficacy, comfort, satisfaction and safety) and the patent strategy. The results will be measured in a Business Plan, a usability test and a European patent application.

Campo scientifico

• social sciences › sociology › social issues › social inequalities

Programma(i)

• H2020-EU.3.5. - SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Argomento(i)

• SMEInst-11-2016-2017 - Boosting the potential of small businesses in the areas of climate action, environment, resource efficiency and raw materials

Invito a presentare proposte

H2020-SMEInst-2016-2017

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEINST-1-2016-2017

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

MY-QUP MEDICAL SL

• Contribution nette de l'UE: € 50 000,00
• Indirizzo: CALLE LLULL 321 ; 08019 BARCELONA ; Spagna
• PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì:
  Regione
  Este › Cataluña › Barcelona
• Regione: Este › Cataluña › Barcelona
• Tipo di attività: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Costo totale: € 71 429,00